Anna Laurenzana
Anna Laurenzana publishes mostly in Molecular Biology, Cancer Research and Biomedical Engineering, on topics such as Angiogenesis and VEGF in Cancer, Protease and Inhibitor Mechanisms and Nanoplatforms for cancer theranostics.
- World rank
- #2,082,748 of 7,710,434 ranked researchers
- Rank in Italy
- #69,090 of 242,206
- Works
- 111
- Citations
- 3k
- Citations per work
- 26.6
What does Anna Laurenzana research?
Anna Laurenzana's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (9%), Engineering (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4540.9%
- Life Sciences4036.0%
- Physical Sciences1513.8%
- Engineering109.0%
- Materials Science54.8%
- Health Sciences109.3%
- Medicine109.3%
- 1Molecular Biology27% of their works
- 2Cancer Research9% of their works
- 3Biomedical Engineering9% of their works
- 4Oncology6% of their works
- 5Materials Chemistry5% of their works
- 6Hematology4% of their works
Research topics
- Angiogenesis and VEGF in Cancer
- Protease and Inhibitor Mechanisms
- Nanoplatforms for cancer theranostics
- Cancer, Hypoxia, and Metabolism
- Histone Deacetylase Inhibitors Research
- Nanoparticle-Based Drug Delivery
- Nanoparticles: synthesis and applications
- Gold and Silver Nanoparticles Synthesis and Applications
Which keywords describe Anna Laurenzana's research?
The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Photothermal Therapy, Cancer Therapy, Biomedical Applications, endothelial progenitor cells, VEGF and Matrix Metalloproteinases.
- Gold Nanoparticles
- Nanocarriers
- HDAC Inhibitors
- Antimicrobial
- HIF-1
- Fluorescence Imaging
- Matrix Metalloproteinases
- VEGF
- Cancer Therapy
- Tumor Targeting
- Nanoparticles
- Photothermal Therapy
- Biomedical Applications
- endothelial progenitor cells
- Tissue Inhibitors of Metalloproteinases
- Reactive Oxygen Species
- Warburg Effect
- Drug Delivery
- Histone Deacetylases
- Toxicity
- Plasmonic Nanoparticles
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Nanoparticles253 topics
- Tumor Targeting182 topics
- Photothermal Therapy172 topics
- Cancer Therapy142 topics
- Biomedical Applications132 topics
- VEGF131 topic
- endothelial progenitor cells131 topic
- Matrix Metalloproteinases121 topic
- Tissue Inhibitors of Metalloproteinases121 topic
- Fluorescence Imaging111 topic
- Reactive Oxygen Species111 topic
- HIF-1101 topic
- Warburg Effect101 topic
- Antimicrobial71 topic
- Drug Delivery71 topic
- HDAC Inhibitors71 topic
- Histone Deacetylases71 topic
- Nanocarriers71 topic
- Toxicity71 topic
- Gold Nanoparticles61 topic
- Plasmonic Nanoparticles61 topic
Where does Anna Laurenzana work?
Anna Laurenzana's main affiliation in the publication record is University of Florence, Italy.
How many publications and citations does Anna Laurenzana have?
OpenAlex counts 111 works and 2,952 citations for Anna Laurenzana, an h-index of 33, ranking #2,082,748 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna Laurenzana. Posts are plain text and can be reported.